Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Date Title and Summary View
Oct 01, 2013
PTC THERAPEUTICS EXPANDS MANAGEMENT TEAM SOUTH PLAINFIELD, NJ – October 1, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Mr. Martin Rexroad as Senior Vice President, Human Resources and Mr. R.A. Session II as Vice President, Corporate Development, both
Additional Formats
Sep 30, 2013
SOUTH PLAINFIELD, NJ – September 30, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it was included on the list of quarterly initial public offering additions to the Russell 2000® Index to be effective at the close of the U.S. market on September 30, 2013.
Additional Formats
Sep 27, 2013
PTC THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES SOUTH PLAINFIELD, NJ – September 27, 2013 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will participate in two upcoming investor conferences. - Management will participate in a roundtable discussion at the
Additional Formats
Sep 25, 2013
SOUTH PLAINFIELD, NJ – September 25, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that four posters will be presented at the 18th International World Muscle Society Congress (WMS) in Asilomar, California, on October 1-5. The following posters will be presented on October 3 from 14:30 -
Additional Formats
Sep 18, 2013
PTC THERAPEUTICS TO PRESENT AT EUROPEAN PEDIATRIC NEUROLOGY SOCIETY CONGRESS SOUTH PLAINFIELD, NJ – September 18, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that two abstracts have been accepted for the 10th European Pediatric Neurology Society Congress (EPNS) in Brussels,
Additional Formats
Aug 29, 2013
PTC THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES SOUTH PLAINFIELD, NJ – August 29, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will participate in following conferences in September: - Stuart W. Peltz, Ph.D., Chief Executive Officer of PTC
Additional Formats
Aug 26, 2013
-Two publications further validate the use of 6MWT as a primary endpoint in Duchenne Muscular Dystrophy (DMD) clinical trials-
Additional Formats
Aug 12, 2013
-- Conference call to be held today at 4:30 p.m. ET --
Additional Formats
Supporting Materials
Aug 08, 2013
- PTC to Receive $10 Million Payment from Roche -
Additional Formats
Aug 06, 2013
PTC THERAPEUTICS TO PRESENT AT WEDBUSH CONFERENCE SOUTH PLAINFIELD, NJ – August 6, 2013 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Shane Kovacs, Chief Financial Officer of PTC Therapeutics will present a company overview at the Wedbush Securities Life Sciences Management
Additional Formats